Evidence map›Paper›PMID 37666689›Full record

ReviewJournal of clinical lipidology

Diet-derived and diet-related endogenously produced palmitic acid: Effects on metabolic regulation and cardiovascular disease risk.

Carmen E Annevelink, Philip A Sapp, Kristina S Petersen, Greg C Shearer, Penny M Kris-Etherton

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of clinical lipidology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
15.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Connecting a Western diet, palmitic acid, and enteric neuropathy.The Journal of clinical investigation · 2026
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Chemical Profiling andNutrients · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Carmen E AnnevelinkDepartment of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, USA.
Philip A SappDepartment of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, USA.
Kristina S PetersenDepartment of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, USA.
Greg C ShearerDepartment of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, USA.
Penny M Kris-EthertonDepartment of Nutritional Sciences, Pennsylvania State University, University Park, PA 16802, USA. Electronic address: pmk3@psu.edu.
Pennsylvania State University · US

Funding

Free fatty acid receptor 4 cardioprotective effects in cardiac ischemic injuryR01HL152215 · NHLBI · UNIVERSITY OF MINNESOTA · PI O'CONNELL, TIMOTHY D, SHEARER, GREGORY C · 2020 to 2024
$3.4M
Research Training in Physiological Adaptations to StressT32GM108563 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI CANTORNA, MARGHERITA T, KORZICK, DONNA HOPE · 2014 to 2023
$2.2M
NHLBI NIH HHS R01 HL152215NIGMS NIH HHS T32 GM108563
6 · The paper itself

Abstract

Palmitic acid is the predominant dietary saturated fatty acid (SFA) in the US diet. Plasma palmitic acid is derived from dietary fat and also endogenously from de novo lipogenesis (DNL) and lipolysis. DNL is affected by excess energy intake resulting in overweight and obesity, and the macronutrient profile of the diet. A low-fat diet (higher carbohydrate and/or protein) promotes palmitic acid synthesis in adipocytes and the liver. A high-fat diet is another source of palmitic acid that is taken up by adipose tissue, liver, heart and skeletal muscle via lipolytic mechanisms. Moreover, overweight/obesity and accompanying insulin resistance increase non-esterified fatty acid (NEFA) production. Palmitic acid may affect cardiovascular disease (CVD) risk via mechanisms beyond increasing low-density lipoprotein-cholesterol (LDL-C), notably synthesis of ceramides and possibly through branched fatty acid esters of hydroxy fatty acids (FAHFAs) from palmitic acid. Ceramides are positively associated with incident CVD, whereas the role of FAHFAs is uncertain. Given the new evidence about dietary regulation of palmitic acid metabolism there is interest in learning more about how diet modulates circulating palmitic acid concentrations and, hence, potentially CVD risk. This is important because of the heightened interest in low carbohydrate (carbohydrate controlled) and high carbohydrate (low-fat) diets coupled with the ongoing overweight/obesity epidemic, all of which can increase plasma palmitic acid levels by different mechanisms. Consequently, learning more about palmitic acid biochemistry, trafficking and how its metabolites affect CVD risk will inform future dietary guidance to further lower the burden of CVD.

Indexed as

Cardiovascular DiseasesPalmitic AcidCarbohydratesCeramidesDietary FatsDiet, Fat-RestrictedFatty AcidsHumansObesityOverweightCarbohydratesCeramidesDietary FatsFatty AcidsPalmitic AcidCeramidesCVD riskDiet-derivedEndogenous synthesisFAHFAsPalmitic acid

Identifiers

PMID37666689
PMCPMC10822025
OpenAlexW4385336685

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.